Coherus Corp, based in Reston, VA, is a biopharmaceutical company dedicated to delivering innovative medicines for individuals facing life-altering diseases. Specializing in immuno-oncology therapies, Coherus focuses on developing a diverse portfolio of next-generation treatments to revolutionize cancer care and enhance patient survival rates.
With a pipeline of clinical-stage immuno-oncology drug candidates targeting the tumor microenvironment, Coherus is committed to improving patient outcomes through ongoing clinical trials and groundbreaking research. Their recent FDA approval of Toripalimab TPZI for recurrent or metastatic nasopharyngeal carcinoma underscores their mission to empower innovation and provide new opportunities for those in need of advanced medical solutions.
Generated from the website